ProCE Banner Activity

CAR T-Cell Therapy: Best Practices for Community Providers

Slideset Download
Download these slides from our live meeting series to review key strategies for integrating CAR T-cell therapy into community-based management of patients with hematologic malignancies.

Released: September 06, 2019

Expiration: September 04, 2020

No longer available for credit.

Share

Faculty

Michael R. Bishop

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

Jae H. Park

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

Supported by educational grants from

Celgene

Gilead Sciences, Inc.

Kite A GILEAD Company

Faculty Disclosure

Primary Author

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York